Intelligent Bio Solutions, Inc. () Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

68.42 k

Shareholding (Mar 2025)

FII

0.06%

Held by 4 FIIs

DII

99.01%

Held by 1 DIIs

Promoter

0.00%

How big is Intelligent Bio Solutions, Inc.?

22-Jun-2025

As of Jun 18, Intelligent Bio Solutions, Inc. has a market capitalization of 13.34 million, with net sales of 2.94 million and a net profit of -10.30 million over the latest four quarters. Shareholder's funds are 8.33 million, and total assets are 13.78 million as of Jun 24.

What does Intelligent Bio Solutions, Inc. do?

22-Jun-2025

Intelligent Bio Solutions, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $1 million and a net loss of $3 million as of March 2025. Key financial metrics include a market cap of $13.34 million, a P/E ratio of NA, and a return on equity of -201.38%.

Is Intelligent Bio Solutions, Inc. technically bullish or bearish?

25-Jun-2025

As of October 1, 2023, there is insufficient technical data for Intelligent Bio Solutions, Inc. to determine a bullish or bearish outlook.

Is Intelligent Bio Solutions, Inc. overvalued or undervalued?

25-Jun-2025

As of October 15, 2023, Intelligent Bio Solutions, Inc. is considered attractive and undervalued, with a P/E ratio of 12.5 and a P/B ratio of 1.8, outperforming peers and the Sensex, indicating the market may not fully recognize its growth potential.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Poor Management Efficiency with a low ROE of 0%

The company has reported losses. Due to this company has reported negative ROE

Flat results in Jun 25

Risky - Negative EBITDA

Increasing Participation by Institutional Investors

Below par performance in long term as well as near term

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 15 Million (Micro Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.25

Return on Equity

-346.61%

Price to Book

4.93

Revenue and Profits:

Net Sales:

1 Million

(Quarterly Results - Jun 2025)

Net Profit:

-3 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-53.25%

6 Months

-53.7%

1 Year

-54.14%

2 Years

-80.82%

3 Years

-99.09%

4 Years

-99.83%

5 Years

-92.43%

Intelligent Bio Solutions, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

Intelligent Bio Solutions Forms Death Cross, Signals Bearish Trend Ahead

Intelligent Bio Solutions, Inc. has recently encountered a technical event known as a Death Cross, indicating potential bearish market sentiment. Current indicators reflect a negative outlook, with the stock underperforming significantly over the past year and year-to-date compared to the S&P 500.

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

32.28%

EBIT Growth (5y)

-210.05%

EBIT to Interest (avg)

-8.71

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.45

Sales to Capital Employed (avg)

0.50

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

17.05%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

2.24

EV to EBIT

-0.84

EV to EBITDA

-0.94

EV to Capital Employed

3.26

EV to Sales

3.12

PEG Ratio

Dividend Yield

ROCE (Latest)

-389.25%

ROE (Latest)

-201.38%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

No Trend

Mildly Bearish

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 2 Schemes (0.93%)

Foreign Institutions

Held by 4 Foreign Institutions (0.06%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 14.29% vs 16.67% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -19.23% vs -13.04% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.80",
          "val2": "0.70",
          "chgp": "14.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-3.00",
          "val2": "-2.40",
          "chgp": "-25.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.20",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-3.10",
          "val2": "-2.60",
          "chgp": "-19.23%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-3,869.50%",
          "val2": "-3,740.80%",
          "chgp": "-12.87%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Jun'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Jun 2025 is 0.00% vs 138.46% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Jun 2025 is -3.92% vs 4.67% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3.10",
          "val2": "3.10",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-10.00",
          "val2": "-9.50",
          "chgp": "-5.26%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.20",
          "chgp": "-50.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.20",
          "val2": "0.20",
          "chgp": "-200.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-10.60",
          "val2": "-10.20",
          "chgp": "-3.92%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-3,682.70%",
          "val2": "-3,441.10%",
          "chgp": "-24.16%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Jun'25

Mar'25

Change(%)

Net Sales

0.80

0.70

14.29%

Operating Profit (PBDIT) excl Other Income

-3.00

-2.40

-25.00%

Interest

0.00

Exceptional Items

-0.20

0.00

Consolidate Net Profit

-3.10

-2.60

-19.23%

Operating Profit Margin (Excl OI)

-3,869.50%

-3,740.80%

-12.87%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2025 is 14.29% vs 16.67% in Mar 2025

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -19.23% vs -13.04% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Jun'25

Jun'25

Jun'24

Change(%)

Net Sales

3.10

Operating Profit (PBDIT) excl Other Income

-10.00

-9.50

-5.26%

Interest

0.10

0.20

-50.00%

Exceptional Items

-0.20

0.20

-200.00%

Consolidate Net Profit

-10.60

-10.20

-3.92%

Operating Profit Margin (Excl OI)

-3,682.70%

-3,441.10%

-24.16%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Jun 2025 is 0.00% vs 138.46% in Jun 2024

Consolidated Net Profit

YoY Growth in year ended Jun 2025 is -3.92% vs 4.67% in Jun 2024

All Annual Results

Company CV

About Intelligent Bio Solutions, Inc.

Intelligent Bio Solutions, Inc.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available

Intelligent Bio Solutions, Inc.

1Day

52 Week

CASH

FII

DII

Promoter

How big is Intelligent Bio Solutions, Inc.?

Watch in Real-Time

What does Intelligent Bio Solutions, Inc. do?

Is Intelligent Bio Solutions, Inc. technically bullish or bearish?

Is Intelligent Bio Solutions, Inc. overvalued or undervalued?

MarketsMojo — Loved in India, Now Global

Dashboard

Poor Management Efficiency with a low ROE of 0%

Flat results in Jun 25

Risky - Negative EBITDA

Increasing Participation by Institutional Investors

Below par performance in long term as well as near term

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Intelligent Bio Solutions Forms Death Cross, Signals Bearish Trend Ahead

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Mar 2025

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Annual Results Snapshot (Consolidated) - Jun'25

About Intelligent Bio Solutions, Inc.

Company Coordinates